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Everglades virus (EVEV), an alphavirus in the
Venezuelan equine encephalitis (VEE) serocomplex, circu-
lates among rodents and vector mosquitoes and infects
humans, causing a febrile disease sometimes accompa-
nied by neurologic manifestations. EVEV circulates near
metropolitan Miami, which indicates the potential for sub-
stantial human disease, should outbreaks arise. We char-
acterized EVEV infection of cotton rats in South Florida,
USA to validate their role in enzootic transmission. To eval-
uate whether the viremia induced in cotton rat populations
regulates EVEV distribution, we also infected rats from a
non–EVEV-endemic area. Viremia levels developed in rats
from both localities that exceeded the threshold for infec-
tion of the vector. Most animals survived infection with no
signs of illness, despite virus invasion of the brain and the
development of mild encephalitis. Understanding the
mechanisms by which EVEV-infected cotton rats resist clin-
ical disease may be useful in developing VEE therapeutics
for equines and humans. 
E
verglades virus (EVEV; Togaviridae: Alphavirus) cir-
culates among rodents and vector mosquitoes in South
Florida and can tangentially infect humans, causing a
febrile disease with occasional neurologic signs. The most
closely related Venezuelan equine encephalitis (VEE)
complex viruses, enzootic subtype ID strains, are the pro-
genitors of subtype IAB and IC strains responsible for
major epidemics and epizootics (1). This relationship rais-
es the possibility of epidemic emergence in South Florida,
involving mutations in the EVEV genome, with serious
public health consequences for >2 million people in met-
ropolitan Miami-Dade County. 
EVEV was first recognized in South Florida in the
1960s, when Seminole persons living north of Everglades
National Park were shown to have seroprevalence as high
as 58% (2). Recorded EVEV activity has been limited to
South-Central Florida from Everglades National Park,
north to Indian River County (Figure 1) (3–10). Although
EVEV circulation in South Florida has been documented
repeatedly, little is known about the dynamics of its ecolo-
gy and transmission. Strains isolated from mosquitoes, lab-
oratory transmission experiments (11), and rodent host
preferences (12) found that Culex (Melanoconion) cedecei
was the primary vector. Field studies in the 1960s impli-
cated cotton rats (Sigmodon hispidus, subspecies not
reported) and cotton mice (Peromyscus gossypinus) as
reservoirs on the basis of high seroprevalence for EVEV
(4–6,8). Subsequent studies characterized EVEV and relat-
ed VEEV infection in experimentally infected cotton rats
and laboratory rodents (13–16). However, the duration and
magnitude of viremia titers needed to infect mosquito vec-
tors, the clinical outcome of infection, and the immune
response were never defined in cotton rats from the
enzootic region. To better understand the enzootic EVEV
cycle, we experimentally infected cotton rats from South
Florida.
Factors that regulate the geographic distributions of
arboviruses are poorly understood. Animals of different
genetic backgrounds can show differential susceptibility
and responses to infection with mosquito- and rodentborne
viruses (17–19). For example, rodents most closely related
to reservoir species of hantaviruses are more susceptible to
infection than more distantly related species are (20).
Variation in the susceptibility of cotton rats to EVEV
might explain why its distribution is restricted to South
Florida. Twelve currently recognized subspecies of cotton
rats native to the southern United States (21) differ by as
much as 5% in their cytochrome b DNAsequences (22). If
genetically distinct cotton rat populations living outside
the EVEV-enzootic region do not sustain the magnitude or
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bers of vectors, they could be incapable of maintaining
virus circulation. To test this hypothesis, we compared
EVEV infection in a sympatric cotton rat subspecies to
infection in a genetically divergent Texas subspecies out-
side the known EVEV and VEE complex alphavirus dis-
tribution (22). 
Materials and Methods 
Virus Strains 
Two EVEV strains from ENP were used in the experi-
mental infections: the prototype strain, FE3-7c, isolated in
1963 from Culex (Melanoconion) spp. mosquitoes, was
passaged five times in suckling mouse brains (SMB) and
twice in Vero cells (23), and FE4-71k (SMB1, Vero 1), a
1964 isolate from Culex spp. mosquitoes. Both isolates
were used to assess strain variation and to determine any
effects of the more extensive passage history of FE3-7c on
infection or virulence. Virus stocks were prepared in Vero
cells, and each animal was inoculated with approximately
1,000 PFU. All inocula were back-titered by plaque assay
to determine the exact dose administered.
Cotton Rat Collection, Identification, and Colonization 
Cotton rats were collected in baited live traps (Sherman
Traps Inc., Tallahassee, FL) in April 2003 in Homestead
Air Reserve Base (25.49°N, 80.38°W) within the EVEV-
enzootic region of southern Florida. All procedures were
approved by the University of Texas Medical Branch
Institutional Animal Care and Use Committee and were
performed in accordance with published guidelines (24).
All rats were seronegative and virus-negative for several
rodentborne pathogens enzootic in South Florida, includ-
ing hantaviruses, arenaviruses, eastern equine encephalitis
virus, and EVEV. First generation (F1) offspring from mat-
ing pairs established in the laboratory were used for infec-
tions. To represent a cross-section of the natural
population, rats of various ages (3, 6, 9–12 weeks) were
infected. In most cases, infected animals and mock-infect-
ed controls were matched for age and sex. In addition to
morphologic identification of the animals to the species
level, DNA was extracted from the liver and purified by
using the DNeasy extraction kit (Qiagen, Valencia, CA) or
whole blood using the methods of Longmire et al. (25),and
the cytochrome b gene was amplified and sequenced as
described previously for cotton rat identification (22,26). 
A second cohort of cotton rats, representing a different
subspecies, was collected in Galveston Island State Park
(29.27°N, 94.83° W) in June and August 2003 and used
directly for experimental infections. Texas rats were cho-
sen for the following reasons: 1) among U.S. subspecies,
Texas cotton rats are the most divergent genetically from
the Florida subspecies (26) and may exhibit a difference in
susceptibility; 2) because the subspecies of cotton rats in
which EVEV activity was detected previously is unknown,
we wanted to test a subspecies unexposed to VEEV com-
plex viruses; and 3) the use of local rats simplified animal
use protocols. Although no VEE complex alphaviruses are
known to circulate in Texas, all rats were tested and deter-
mined to be EVEV seronegative before infection. The ages
of the field-collected rats were unknown, but their weights
ranged from 50 g to 160 g, which represents the range of
ages in natural populations of cotton rats because weight
can be used to estimate life stage and age (27). The Texas
rats were matched for sex and size, and the cytochrome b
gene was sequenced.
Cotton Rat Infections
Cohorts of eight cotton rats from each location were
injected subcutaneously (SC) in the left thigh with EVEV,
and two rats per cohort were sham-injected with diluent.
The virus dose (2.3–3.6 log10 PFU) and infection route is
an appropriate simulation of the bite of alphavirus-infect-
ed mosquitoes (28,29). Individually housed animals were
monitored daily for signs of illness typical of VEE com-
plex virus infection and were bled from the retroorbitus at
1- to 2-day intervals, beginning 1 day postinfection. 
In a subsequent experiment, 15 Florida rats (5–22
weeks of age) were administered 3.2 log10 PFU of strain
FE4-71k SC and were serially killed at daily intervals (two
rats/day) for histologic examination and virus assay of
selected organs. Surviving animals were bled daily.
Anesthetized rats were perfused with 20 mL to 50 mL of
phosphate-buffered saline to eliminate viremic blood from
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Figure 1. Map of South Florida, indicating locations of Everglades
virus isolation, human cases or antibody detection (stars), and our
cotton rat collection site (box). Dark line delineates national park
boundary.the organs, and organs were homogenized (MM300
homogenizer, Retsch Inc., Newton, PA) in Eagle’s mini-
mum essential medium (MEM) with 5% fetal bovine
serum to yield a 10% weight/volume suspension. Each
suspension was centrifuged at 5,760 x g for 6 min, and the
supernatant was frozen at –80°C. Additional tissue sam-
ples were transferred to 10% formalin for 48 h and then
stored in 70% ethanol before being embedded in paraffin,
sectioned, and stained with hematoxylin and eosin.
Sections were examined in a blinded manner for
histopathologic lesions characteristic of VEEV infections
of mice and hamsters (30,31). 
Virus and Antibody Assays 
Serum and organ samples were tested for EVEV by
plaque assay on Vero cells (32). Log- transformed viremia
levels were compared among cohorts by using the Mann-
Whitney U test (33). The limit of detection of the assay
was 80 PFU/mL (1.9 log10 PFU/mL). Antibody titers were
measured by standard 80% plaque reduction neutralization
tests (PRNT) (32).
Results
Identification of Cotton Rats. 
Genetic distances among mitochondrial cytochrome b
gene sequences of rats from Florida and Texas were
obtained by using the Kimura 2-parameter model (34) and
were used to construct a neighbor-joining tree (35) that
reflected phylogenetic relationships (data not shown).
Texas rats grouped closely with S. hispidus berlandieri,
and Florida rats were identified as S. hispidus spadicipy-
gus, another subspecies that differs by up to 5% in its
sequence from berlandieri, which suggests that these pop-
ulations represent the maximum level of divergence with-
in the United States.
Infection Profile and Virus Replication Kinetics 
A total of 46 of the 47 cotton rats from both localities
injected with EVEV became viremic for 3 to 4 days
(Figure 2). With the exception of a single death approxi-
mately 30 hours postinfection, all rats survived, and none
exhibited detectible illness. The rat that died had viremia
and organ titer levels comparable to levels in other rats 1
day postinfection. Rats from Texas did not experience
viremia levels of shorter duration or lower magnitude (p >
0.05) than Florida animals, causing us to reject our hypoth-
esis that Texas animals are less likely to exhibit EVEV
viremia. Strain FE3-7c produced lower viremia titers than
FE4-71k at 1 and 2 days postinfection; however, only dif-
ferences in Florida rats were significant (p = 0.02 day 1,
p = 0.03, day 2). Mean peak titers occurred 2–3 days
postinfection and reached 4–4.5 log10 PFU/mL for all
cohorts. By day 4, viremia levels were not detectable in
most rats. Viremia profiles were independent of sex, age,
or sibling relatedness among the colony Florida rats (data
not shown). 
Pathologic Manifestations and Viral Tropism 
Although a single rat died approximately 30 hours
postinfection, none of the other 46 infected rats exhibited
signs of illness. The viremia profile for rats sacrificed daily
(Figure 3A) showed no difference from that generated in
the first experiment with animals from the same location
infected with the same virus isolate (Figure 2A). Figure 3
shows the temporal course of organ infection in the heart,
brain, salivary glands, and lungs (B) and spleen, kidney
and liver (C). EVEV was detected in the heart (1–2 days
2184 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 12, December 2004
RESEARCH
Figure 2. Viremia and neutralizing antibody
profile in F1 Florida (panels A, B) or wild
Texas (panels C, D) cotton rats injected with
Everglades virus strains FE4-71k (A, C) and
FE3-7c (B, D) administered subcutaneously
in the left thigh. Inoculum doses were as fol-
lows: panels A and B: 2.9 log10 PFU/mL,
panel C: 2.3 log10 PFU/mL, panel D: 3.6 log10
PFU/mL. Florida animals were bled daily;
viremia or 80% plaque reduction neutraliza-
tion test (PRNT) antibody titers represent
geometric means of data from eight rats
(strain FE3-7c) or seven rats (EVEV FE4-
71k). Rats from Texas were each bled every
2 days; means (geometric) represent meas-
urements from four animals. Bars denote
standard deviations.postinfection), salivary glands (3–4 days postinfection),
lungs (1–4 days postinfection), brain (2–4 days postinfec-
tion) (Figure 3B), and in the spleen (1–3 days postinfec-
tion), and inconsistently in the liver (2–4 days
postinfection) and kidney (1–6 days postinfection) (Figure
3C). Aside from virus in the kidney of one rat at day 6
postinfection (Figure 3C), virus was cleared from all
organs by day 5, which coincided with the development of
neutralizing antibodies (described below). We were unable
to detect virus in urine or fecal samples collected 1–7 days
postinfection. 
Histopathologic examinations showed depletion of
lymphoid cells in the spleen on day 2, followed by archi-
tectural reorganization and recovery 3 to 7 days postinfec-
tion (not shown). Brains of infected rats appeared similar
to those of mock-infected rats until 4 days postinfection,
coincident with virus clearance from the blood. After day
4, focal meningoencephalitis and associated perivascular
mononuclear cell infiltration and neurophagia were
observed. Figure 4 shows brain sections from sham-inocu-
lated (A) and encephalitic rats infected with strain FE4-
71k that were killed on day 7 postinfection (B), and
approximately 5 weeks postinfection (C). The focal
encephalitis observed in infected rats at 7 days postinfec-
tion was resolved by 5 weeks postinfection, without chron-
ic inflammation or tissue reorganization.
Antibody Responses
All 46 surviving cotton rats seroconverted; neutralizing
antibody was first detectable 5 days postinfection, concor-
dant with or after the disappearance of viremia (Figures
2A–D, 3A). Levels of neutralizing antibody rose rapidly to
maximum mean titers of 320 to 28,157 (Figures 2A–D,
3A), and some rats maintained high (>10,240) neutralizing
antibody titers for 6 months.
Discussion 
Infection Outcome 
EVEV produced benign, systemic infection when
delivered SC in relevant doses to cotton rats from EVEV-
endemic and EVEV-nonendemic areas of the United
States, and all surviving animals seroconverted. The
appearance of antibody sometimes followed the disappear-
ance of viremia, indicating that innate immune mecha-
nisms may participate in virus clearance or that
undetectable levels of neutralizing antibody may have pre-
ceded the disappearance of viremia. The lower levels of
viremia generated by strain FE3-7c may reflect the more
extensive cell culture passage history of this isolate. The
nonfatal outcome of infection, combined with the high lev-
els of viremia and observations from field studies (4–6,8),
is consistent with the role of cotton rats as reservoir hosts
for EVEV. 
EVEV was neuroinvasive in cotton rats and caused
transient, focal encephalitis as well as mild viscerotropic
diseases, similar to those caused by other VEE complex
alphaviruses. Although encephalitis developed in cotton
rats, their ability to clear virus from the brain and the rela-
tively minor inflammatory response they mounted
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Figure 3. A) Viremia and neutralizing antibody profiles in F1 Florida
cotton rats serially sacrificed at daily intervals after infection with
3.2 log10 PFU of Everglades virus strain FE4-71k administered
subcutaneously in the left thigh. Lines on each graph represent the
geometric mean viremia or mean 80% plaque reduction neutral-
ization test (PRNT) antibody titers; the number of rats bled at each
time point is denoted in parentheses above each point. Error bars
denote standard deviations. Everglades virus organ titers from the
brain, salivary glands, lung and heart (B) and liver, kidney, and
spleen (C) of EVEV strain FE471k-infected F1 Florida cotton rats
serially sacrificed at daily intervals. Two rats, denoted “a” and “b”
were sacrificed daily from days 1–7 postinfection. No virus was
detected in any organ on day 7.
B
Ccontrasts dramatically with EVEV or VEEV infection of
mice (36) and warrants further study. 
In many respects, our results were similar to published
cotton rat infection profiles of animals and VEE complex
viruses from other localities. Wild-caught Panamanian cot-
ton rats (probably S. h. hirsutus) (26) that had been inject-
ed with 2.8 log10 PFU of an enzootic VEEV subtype ID
strain exhibited no virus-induced deaths, but viremia titers
developed of 3.7 days mean duration with a peak median
magnitude of 7.1 log10 VeroPFU/mLat day 2 postinfection
(13), three orders of magnitude higher than the viremia
levels we measured. Howard (16) reported that 9 (45%) of
20 cotton rats captured in central Florida near Tampa died
after injection with 3.8 log10 suckling mouse intracerebral
lethal dose 50% (SCILD50) of a VEEV subtype IAB iso-
late, and a peak viremia level of 6.0 log10 PFU/mL devel-
oped in the surviving animals at day 2 postinfection.
Possible explanations for the differences in VEE complex
viremia levels in different rat populations include the fol-
lowing: 1) EVEV may generally replicate at lower levels
in a variety of rodents, or 2) cotton rats from southern
Florida are more resistant to the replication of VEE com-
plex alphaviruses. Infection of cotton rats from southern
Florida with other VEE complex strains is needed to test
this hypothesis.
The only other reported experimental infections of
North American cotton rats with EVEV involved seven
animals from Homestead, Florida (C. Calisher, pers.
comm.), which became viremic 2–4 days postinfection,
with a peak of 6.4 log10 SMICLD50/mL 3 days postinfec-
tion and no deaths (15). This peak viremia level is approx-
imately equal to our 4.0 PFU/mL value measured by
plaque assays, since the SMICLD50:PFU ratio for EVEV is
approximately 200:1 (L. L. Coffey, unpub. data).
Cotton Rats as Reservoirs of EVEV 
The fact that high numbers of infected cotton rats in our
study survived contrasts with results from EVEV infec-
tions of laboratory rodents and is consistent with their role
as natural reservoirs. Golden Syrian hamsters and Swiss
albino mice experience 75%–100% mortality with doses
as low as 3 log10 Vero PFU, and pathologic lesions devel-
op, consistent with VEE-like disease (14,30,37,38). Even
though infection of laboratory rodents often causes death,
EVEV infection is less virulent than most other VEE com-
plex viruses, which generally cause 100% of infected ani-
mals to die (14,30,31,38). 
For EVEV transmission by a vector, the reservoir must
attain a threshold viremia level (minimum virus titer that
infects approximately 1%–5% of vectors [39]).
Susceptibility studies of Culex (Mel.)  cedecei indicated
that hamster blood meal titers as low as 0.9 log10 chicken
embryo cell (CEC) PFU/mL (even lower than the viremia
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Figure 4: Brainstem section of sham-inoculated control rat, show-
ing the absence of an inflammatory response (A). Vascular and
perivascular infiltration of mononuclear cells within the brainstem
of a Florida cotton rat 7 days after infection with 3.2 log10 PFU/mL
EVEV strain FE4-71k; inset enlarged to show cell infiltration (B).
Cortex of cotton rat 5 weeks after infection, showing absence of
inflammatory response (C). Animals in panels A and B were anes-
thetized with pentobarbital and perfused with phosphate-buffered
saline intracardially. The rat in panel C was not perfused.detection limit in our study) infected 9% of mosquitoes,
and infected Cx. cedecei transmitted EVEV to naïve ani-
mals after extrinsic incubation (11). With oral doses of 4.9
log10 CEC PFU/mL, slightly higher than the peak viremia
levels observed in our cotton rats, 100% of Cx. cedecei
became infected. One EVEV Vero cell PFU approximates
one CEC PFU (L. L. Coffey, unpub. data), indicating that
the infection threshold for Cx. cedecei is lower than the
detection limits of our assays. Therefore, any viremia lev-
els we observed should be sufficient to infect at least some
Cx. cedecei. 
The absence of virus in excreta from any of the infect-
ed animals indicates that EVEV is probably not transmit-
ted horizontally between nest-mates through this route,
despite the detection of virus in the kidney. However, the
possibility of persistent infection should be addressed in
further studies. 
EVEV Distribution 
Our data do not support the hypothesis that variation in
the susceptibility of cotton rats explains the limited EVEV
distribution. Another explanation supported by susceptibil-
ity testing (11) is that the mosquito vector limits EVEV
distribution. The recorded distribution of Cx. cedecei is
restricted to 13 counties in South Florida (40) and closely
parallels the recorded distribution of EVEV activity. 
Potential for EVEV Disease 
Understanding arbovirus transmission cycles is impor-
tant for delineating the epidemiology of human disease.
Our data support the role of cotton rats as EVEV reservoirs
in South Florida. Future work should focus on cotton rat
ecology, with emphasis on population dynamics.
Combined with quantitative information about vector-
reservoir contact, mosquito population fluctuations, and
virus circulation intensities, EVEV transmission dynamics
can be elucidated. 
Previous studies (1,41) indicate that epidemic VEEV
emerges from enzootic subtype ID strains, the closest rel-
atives of EVEV. Only a few mutations in enzootic VEEV
can generate viruses with equine amplification phenotypes
(42). If such epidemic EVEV strains arise, substantial
human illness or deaths could occur. Reverse genetic stud-
ies under way in our laboratory are designed to assess this
possibility.
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